Marijuana is the most common mood-altering drug used during pregnancy, and with legalization occurring in several states, there is concern that its use may increase. This ACOG Committee Opinion provides a comprehensive summary of current evidence regarding risks of recreational or medicinal marijuana use during pregnancy and lactation to both the mother and the fetus.
Postpartum Pre-/Inter-conception Prenatal
Clinical Guidelines/Expert Recommendations for Providers
Back to Evidence-Based Practices »
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UF5MC26845 titled Supporting Healthy Start Performance Project for grant amount $1,170,492. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.